JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 30, 2006; DOI: 10.1124/jpet.106.108902


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108902v1
319/3/1386    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabiyi, A. C.
Right arrow Articles by Brading, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabiyi, A. C.
Right arrow Articles by Brading, A. F.


Received for publication June 5, 2006.
Revised August 12, 2006.
Accepted for publication August 28, 2006.

The Use of the Isolated Mouse Whole Bladder for Investigating Bladder Overactivity

Adebola C. Fabiyi 1* Alison F. Brading 1

1 University of Oxford

* Address correspondence to: E-mail: adebola.fabiyi{at}nds.ox.ac.uk

Abstract

The isolated mouse whole bladder was used to study in vitro bladder overactivity evoked by intramural nerve sensitization with bradykinin, mimicking neurogenic bladder overactivity secondary to bladder inflammation. Intravesical pressure responses to intramural electrical stimulation (EFS) of intramural nerves were measured under isovolumetric condition. Validation showed that carbachol produced a dose response curve closely mirroring that observed in the isolated muscle strips, and demonstrated the dual nature of electrically evoked neurotransmission, consisting of a cholinergic component largely mediated by M3 receptors and a purinergic component mediated by P2X receptors. ATP generated a biphasic dose response curve, suggesting that the P2X receptors may be heterogeneous in distribution. Characterization of bradykinin receptors showed bradykinin to be extremely potent in exciting the bladder, producing a dose response curve with an EC50 of 90nM, and bradykinin also enhanced electrically evoked bladder contractions. These effects were inhibited by the B2 receptor antagonist HOE 140 but not the B1 receptor antagonist desArge10HOE 140 and were also modulated by {alpha},{beta},methyleneATP. The isolated mouse whole bladder has proved a viable, robust model in which to demonstrate the pharmacological characteristic of the bladder, and adds to the repertoire of in vitro tools for investigating potential therapeutic agents.


Key words: Bradykinin, bladder overactivity, intravesical pressure, isovolumetric, mouse, purinoceptors


This article has been cited by other articles:


Home page
FASEB J.Home page
A. C Fabiyi and A. F Brading
Neuromodulatory Effect of delta 9-THC on an In Vitro Model of Overactive Bladder Secondary to Bradykinin Sensitization of Intramural Nerves
FASEB J, March 1, 2007; 21(6): LB85 - LB85.





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.